4
692
W.-P. Deng et al. / Tetrahedron: Asymmetry 10 (1999) 4689–4693
spectrometers, respectively. Elemental analyses were performed on a Foss–Heraeus Vario EL instrument.
Enantiomeric excesses were determined by chiral HPLC on a Chiralcel OD column.
0
3
.2. 1-[(S)-4-Isopropyl-2,5-oxazolinyl]-1 -(α-diphenylhydroxymethyl)ferrocene 4
To a solution of 8a (113 mg, 0.3 mmol) in THF (4 mL) was added n-butyllithium (1.6 M in hexane,
0.2 mL, 0.32 mmol) at –78°C. The reaction mixture was stirred for an additional 30 min and then
trapped with benzophenone (109 mg, 0.6 mmol) at this temperature. After stirring at 0°C for 20 min,
the reaction mixture was washed with water and then with brine and dried over Na SO After the
2
4.
solvent was removed under reduced pressure, the residue was purified by column chromatography with
ethyl acetate:petroleum (60–90°C, 1:3) as an eluent to afford 4 (133 mg, 93%) as an orange solid. M.p.
2
5
1
9
1
(
7–98°C. [α] =−86.0 (c 0.2, EtOH). H NMR δ 0.92 (d, J=6.74 Hz, 3H), 1.06 (d, J=6.74 Hz, 3H),
D
.84 (m, 1H), 3.95–4.20 (m, 6H), 4.30–4.46 (m, 3H), 4.76 (s, 3H), 7.17–7.38 (m, 10H). MS m/z 479
M , 100.0), 249 (83.8), 163 (67.8), 229 (65.3), 230 (43.3), 228 (41.9). IR (KBr) 3441, 2955, 1643,
+
1
485, 1117, 753, 768, 485. Anal. calcd for C H NO Fe: C, 72.66; H, 6.10; N, 2.92. Found: C, 72.72;
29 29 2
H, 6.14; N, 3.17.
0
3
.3. 1-[(S)-4-Benzyl-2,5-oxazolinyl]-1 -(α-diphenylhydroxymethyl)ferrocene 5
Compound 8b (212 mg, 0.5 mmol) was allowed to react according to the procedure for 4 to afford 5
2
5
1
(
216 mg, 82%) as an orange solid. M.p. 64–65°C. [α] =−51.0 (c 0.22, EtOH). H NMR δ 2.69 (dd,
D
J=8.94, 13.69 Hz, 1H), 3.25 (dd, J=4.98, 13.7 Hz, 1H), 4.03–4.13 (m, 3H), 4.13–4.21 (m, 2H), 4.25–
+
4
9
7
2
.39 (m, 3H), 4.42–4.56 (m, 1H), 4.62 (br, 1H), 4.77 (s, 2H), 7.19–7.36 (m, 15H). MS m/z 527 (M ,
1.4), 297 (100.0), 279 (51.2), 229 (81.1), 188 (64.5), 91 (67.8). IR (KBr) 2924, 1645, 1489, 1445, 1122,
51, 700, 496. Anal. calcd for C H NO Fe: C, 75.15; H, 5.54; N, 2.66. Found: C, 75.15; H, 5.55; N,
2
9
29
2
.56.
0
3
.4. 1-[(S)-4-tert-Butyl-2,5-oxazolinyl]-1 -(α-diphenylhydroxymethyl)ferrocene 6
Compound 8c (195 mg, 0.5 mmol) was allowed to react according to the procedure for 4 to afford 6
2
5
1
(
9
220 mg, 90%) as an orange solid. M.p. 137–138°C. [α] =−125.0 (c 0.2, EtOH). H NMR δ 0.96 (s,
D
H), 3.97 (dd, J=8.04, 9.71 Hz, 1H), 4.05–4.23 (m, 5H), 4.25–4.35 (m, 2H), 4.38 (s, 1H), 4.75 (d, J=9.25
Hz, 2H), 4.91 (br, 1H), 7.15–7.46 (m, 10H). MS m/z 493 (M , 24.4), 311 (26.4), 310 (95.2), 254 (100.0),
26 (42.4), 211 (53.26). IR (KBr) 3283, 2965, 1648, 1486, 1123, 957, 754, 703, 499 cm . Anal. calcd
+
−
1
2
for C H NO Fe: C, 73.03; H, 6.33; N, 2.84. Found: C, 73.00; H, 6.32; N, 3.12.
2
9
29
2
0
3
.5. 1-[(R)-4-Phenyl-2,5-oxazolinyl]-1 -(α-diphenylhydroxymethyl)ferrocene 7
Compound 8d (205 mg, 0.5 mmol) was allowed to react according to the procedure for 4 to afford 7
2
5
1
(
(
186 mg, 73%) as an orange solid. M.p. 139–140°C. [α] =+98.6 (c 0.21, EtOH). H NMR δ 4.08–4.27
D
m, 5H), 4.37 (dd, J=1.2, 23.1 Hz, 3H), 4.73 (t, J=9.02 Hz, 1H), 4.87 (d, J=11.2 Hz, 2H), 5.27 (t, J=8.26
Hz, 1H), 7.18–7.47 (m, 15H). MS m/z 513 (M , 99.2), 283 (39.9), 229 (57.9), 193 (100.0), 163 (36.6).
IR (KBr) 3260, 1637, 1446, 1121, 1023, 749, 709, 491 cm . Anal. calcd for C H NO Fe: C, 74.86;
+
−1
2
9
29
2
H, 5.30; N, 2.73. Found: C, 74.90; H, 5.29; N, 2.76.